SCHEMBL21028996

SCHEMBL21028996

c1ccc(-c2nc(-c3cccc(-c4cccc(-c5ccc6c(c5)oc5ccccc56)c4)c3)nc(-c3ccc4c(c3)sc3ccccc34)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.38
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
HPGD P15428 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
AHR P35869 2/20 0.37
PLA2G10 O15496 1/20 0.37
RAB9A P51151 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 1/20 0.36
GPR3 P46089 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TTR P02766 1/20 0.35
PRKDC P78527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25557413 1.00 HCRTR1 (0.38) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL25645710 1.00 HCRTR1 (0.38) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL25852034 0.99 PLA2G2A (0.39) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL21029001 0.99 PLA2G2A (0.39) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL25852096 0.99 PLA2G2A (0.39) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL25645706 0.99 PLA2G2A (0.39) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL21028998 0.99 PLA2G2A (0.39) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL21029000 0.99 PLA2G2A (0.39) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL25645714 0.99 PLA2G2A (0.39) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A
SCHEMBL25645650 0.99 PLA2G2A (0.39) HCRTR1MAPTALDH1A1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11678572-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus SAMSUNG SDI CO., LTD. (KR) 2023-06-13 US disclosed
US-11678572-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus SAMSUNG SDI CO., LTD. (KR) 2023-06-13 US disclosed
US-20190181351-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-06-13 US disclosed
US-20190165281-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS SAMSUNG SDI CO., LTD. (KR) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11678572-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus OXER1, OCIAD1, OR10J3 HCRTR1 290/4885MAPT 1973/4885ALDH1A1 59/4885
US-20190181351-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD2, OCIAD1, OR10J3 HCRTR1 761/4885MAPT 1944/4885ALDH1A1 209/4885
US-20190165281-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS OXER1, OCIAD1, OR10J3 HCRTR1 290/4885MAPT 1973/4885ALDH1A1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.